Myasthenia gravis constitutes chronic autoimmune ailment that primarily affects the neuromuscular junction. This junction mediates the transfer of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system mistakenly attacks these receptors, resulting weakness and fatigue in the motor units. The manifestation